Evolution of Tuberculosis/Human Immunodeficiency Virus Services among Different Integrated Models in Myanmar: A Health Services Review.
Myo Su KyiSi Thu AungEdward B McNeilVirasakdi ChongsuvivatwongPublished in: Tropical medicine and infectious disease (2018)
Myanmar is one of the highly affected countries by tuberculosis (TB) and human immunodeficiency virus (HIV) co-infection. We aimed to review the coverage of TB/HIV integrated services as well as to document the performance of this integrated services. A retrospective program review was conducted using the aggregated data of the National TB Programme (NTP) from 2005 to 2016. In Myanmar, TB/HIV services were initiated in seven townships in 2005. Townships were slowly expanded until 2013. After that, the momentum was increased by increasing the government budget allocation for NTP. In 2016, the whole country was eventually covered by TB/HIV services in different types of integration. Antiretroviral therapy (ART) coverage among HIV-positive TB patients remained low and it was the only significant difference among the three types of integration. Barriers of low ART coverage need to be investigated to reduce the burden of TB/HIV.
Keyphrases
- antiretroviral therapy
- human immunodeficiency virus
- hiv positive
- hiv infected
- mycobacterium tuberculosis
- hiv aids
- hiv infected patients
- healthcare
- primary care
- affordable care act
- mental health
- hepatitis c virus
- pulmonary tuberculosis
- end stage renal disease
- clinical trial
- newly diagnosed
- ejection fraction
- randomized controlled trial
- chronic kidney disease
- health insurance
- quality improvement
- big data
- peritoneal dialysis
- mass spectrometry
- adverse drug
- patient reported